A Randomized, Placebo Controlled, Double Masked Phase IB Study Evaluating the Safety and Antiviral Activity of Aprepitant, a Neurokinin-1 Receptor Antagonist in HIV-1 Infected Adults

BACKGROUND: Neurokinin-1 receptor (NK1R) antagonists have anti-HIV activity in monocyte-derived macrophages, decrease CCR5 expression and improve natural killer cell function ex vivo. Aprepitant is a NK1R antagonist approved by FDA as an antiemetic. METHODS: We conducted a phase IB randomized, place...

Descripción completa

Detalles Bibliográficos
Autores principales: Tebas, Pablo, Tuluc, Florin, Barrett, Jeffrey S., Wagner, Wayne, Kim, Deborah, Zhao, Huaquing, Gonin, René, Korelitz, James, Douglas, Steven D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169584/
https://www.ncbi.nlm.nih.gov/pubmed/21931661
http://dx.doi.org/10.1371/journal.pone.0024180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169584/
https://www.ncbi.nlm.nih.gov/pubmed/21931661
http://dx.doi.org/10.1371/journal.pone.0024180

Ejemplares similares